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Abstract
Fragmentation of QRS (fQRS) complex is an easily evaluated non-invasive electrocardiographic
parameter. Fragmentation of narrow QRS is defined as presence of an additional R wave (R’)
or notching in the nadir of the S wave, or the presence of > 1 R’ in 2 contiguous leads,
corresponding to a major coronary artery territory on the resting 12-lead ECG. Fragmentation
of wide complex QRS consists of various RSR patterns, with more than 2 R waves (R’’) or
more than 2 notches in the R wave, or more than 2 notches in the downstroke or upstroke of the
S wave. Presence of fQRS has been associated with alternation of myocardial activation due to
myocardial scar and myocardial fibrosis. Initial studies reported higher sensitivity of fQRS
than Q wave for detecting myocardial scar and postulated that the presence of fQRS could be
a good predictor of cardiac events among the patients with coronary artery disease. The
presence of fQRS has been investigated among the patients with ischemic and non-ischemic
cardiomyopathy suggesting that this ECG parameter may affect prognosis and risk of sudden
cardiac death, risk of implantable cardioverter-defibrillator therapy and response to cardiac
resynchronization therapy. In addition, there is evidence that fQRS could play an important
role as screening and prognostic tool among the patients with Brugada syndrome, long QT
syndrome, arrhythmogenic right ventricular dysplasia and cardiac sarcoidosis. This paper
reviews definition, diagnostic and prognostic value of fQRS in different patient populations.
(Cardiol J 2012; 19, 2: 114–121)
Key words: QRS fragmentation, risk, prognosis, coronary artery disease, Q wave,
myocardial scar, diagnosis
Introduction
Slurring and changes in the morphology of the
QRS complex have been investigated since 1960’s.
Flowers et al. [1] demonstrated that the presence
of fragmented QRS (fQRS) complexes (also called
high-frequency components) are more common
among patients with prior myocardial and among
patients with either right or left ventricular (LV) en-
largement. Fragmentation of QRS but in particular
late potentials, was investigated as a possible new
tool to identify the high risk cardiac population.
Friedman et al. [2], analyzing canine heart with in-
duced myocardial infarction (MI) suggested that
persistent changes in Purkinje fibers and myocar-
dial fibrosis may cause slow and inhomogeneous
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myocardial activation. Gardner et al. [3] proposed
that fQRS complex in infarcted canine heart is
caused by slow and inhomogeneous activation rela-
ted to healed myocardial scar rather than changes
in transmembrane resting or action potentials [3].
In the analysis of data from an epicardial and
endocardial mapping from the patients undergoing
LV aneurysm incision, Wiener et al. [4] demonstrat-
ed that the fragmented electrical activity was
present in all patients with LV aneurysms. Howev-
er, patients with ventricular tachycardia had frag-
mented electrical activity from a larger proportion
of the endocardial border zone and had more pro-
longed electrograms in this zone than patients with-
out ventricular tachycardia. The surgical excision
of the area, which demonstrated fragmented acti-
vity during intraoperative epicardial and endocardial
mapping among the patients with pharmacologically
refractory ventricular arrhythmia, was associated
with better survival and freedom from ventricular
arrhythmia. It was proposed that endocardial elec-
trical activity mapping and detection of fragmented
activity was a useful tool for surgically guided ther-
apy for ventricular aneurysm and ventricular tachy-
cardia [5]. Varriale and Chryssos [6] suggested that
RSR’ complex associated with wide QRS complex
(equal or greater than 110 ms) but unrelated to right
bundle branch block (RBBB) or left bundle branch
block (LBBB), could be associated with impaired de-
polarization within tissue surrounding the myocar-
dial scar. Bayes de Luna [7] suggested that abnor-
malities of the second half of the QRS complex
(terminal slurring, sometimes with R’ in lead V1)
during MI might represent necrosis in late depo-
larized basal zones. There is a large literature on
late potentials assessed using signal-averaged
ECG, but this review is focused on intra-QRS frag-
mentations that could be assessed in a standard
12-lead ECG.
Contemporary definition of the fQRS was de-
fined by Das et al. [8], as presence of an additional
R wave (R’) or notching in the nadir of the S wave,
or the presence of > 1 R’ in 2 contiguous leads,
corresponding to a major coronary artery territory
on the resting 12-lead ECG with filter range 0.16–
–100 Hz, AC filter 60 Hz, paper speed 25 mm/s and
10 mm/mV. Fragmentation of wide complex QRS
(BBB and paced rhythms) was defined by Das et al.
[8], as various RSR patterns with or without a Q wa-
ve, with more than 2 R waves (R’) or more than
2 notches in the R wave, or more than 2 notches in
the downstroke or upstroke of the S wave, in 2 con-
tiguous leads corresponding to a major coronary ar-
tery territory. Figure 1 shows examples of fQRS as
described by Das et al. [8]. In Figure 2, there is an
example of QRr’ pattern in the patient with prior
inferior MI. Definition of fragmented premature
ventricular complexes (PVC) was similar to frag-
mentation of BBB and paced rhythm but also includ-
ed PVC with 2 notches in the R wave which were
more than 40 ms apart and present in 2 contiguous
leads [9]. Examples of fragmentation of RBBB and
LBBB are shown in Figures 3 and 4, respectively.
Fragmented QRS and myocardial scar
Based on this definition of fragmented QRS,
Das et al. [8] compared sensitivity and specificity
of Q wave and fQRS for detecting myocardial scar
in a cohort of 479 consecutive patients with and
without prior history of coronary disease who were
referred for nuclear stress test. In this analysis,
fQRS complexes have higher sensitivity than Q wa-
ves for detecting regional myocardial scar as well
Figure 1. Examples of QRS fragmentations as described by Das et al. [10]. Reproduced with permission [10].
RSR’ rSr’ rSR’ Notched S Notched R Fragmented
QRS
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fQRS was less specific than Q wave for myocardial
scar (85.6% vs 99.2%). Using similar cohort of pa-
tients, Das et al. [10] demonstrated that the pres-
ence of fQRS was associated with higher all-cause
mortality (34% vs 26% in patients without fQRS)
and cardiac event rate (Fig. 5) defined as MI, cardiac
death and need for revascularization (50% vs 28%
in patients without fQRS). In the multivariate Cox
regression analysis, fQRS was independent predic-
tor of cardiac events (HR 1.62; p = 0.0001) but no
all-cause mortality (HR 1.07; p = 0.62).
In a cohort of 879 patients with wide QRS
(equal or more than 120 ms, including BBB, PVC,
or paced QRS), referred for nuclear stress testing
or cardiac catheterization for evaluation of coronary
artery disease (CAD), presence of fragmented wide
QRS complex was associated with high sensitivity,
specificity of myocardial scar and high positive pre-
dictive value, negative predictive value (86.8%,
92.5%, 92%, and 87.5%, respectively). When ana-
lyzing outcome data, fQRS was associated with an
increased risk of all-mortality after adjustment for
age, ejection fraction (EF) and history of diabetes
mellitus [9].
Pietrasik et al. [11] studied patients with first
Q-wave MI and effect of fQRS, resolved Q wave,
and persistent Q wave on 2 month follow-up ECG
on the risk of recurrent cardiac events defined as
unstable angina, recurrent MI or cardiac death. In
this study, fQRS was associated with higher risk of
recurrent events among the patients who resolved
Q wave. It was proposed that fQRS may identify
ischemic myocardium [11]. In another cohort of
Figure 2. QRr’ pattern in the patient with prior inferior
myocardial infarction.
Figure 4. QRS fragmention in the inferior leads in the
patient with left bundle branch block and ischemic car-
diomyopathy.
Figure 5. Kaplan-Meier analysis showing cardiac events
in patients with fragmented QRS (fQRS group) and wi-
thout fragmented QRS (non-fQRS group). Reproduced
with permission [10].
Figure 3. QRS fragmentation in the anterior leads in
the patient with right bundle branch block and dilated
cardiomyopathy.
as detecting myocardial scar independently of the
regional correlation (fQRS vs Q wave: 85.6% vs
36.3%). However, when comparing specificities,
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56 patients, fQRS seemed to correlate with chronic
total coronary occlusion with poorly developed col-
lateral coronary circulation in patients without pri-
or MI [12]. In contrary to those findings, 2 studies
failed to show significant association between fQRS
and myocardial scar. Wang at el. [13] reassessed
sensitivity and specificity of fragmented QRS for
detecting myocardial scar. ECG and nuclear perfu-
sion images of 460 consecutive patients with known
or suspected CAD were correlated. Q wave has bet-
ter sensitivity than fQRS in detecting myocardial
scar (31.7% vs 1.7%). Similar results were found by
Carey et al. [14], in a cohort of 138 patients with
severely depressed LV systolic function (mean EF
27 ± 9%) who had infarct volume assessed by
positron emission tomography. In this population,
fQRS was not predictive for infarct size in both pa-
tients with narrow and wide QRS complex [14].
Table 1 summarizes key studies evaluating the as-
sociation between fQRS and myocardial scar.
QRS fragmentation and cardiac events
in coronary artery disease
Significance of the appearance of fQRS in the
patients with acute coronary syndrome has been
investigated. In the cohort of 896 patients with acute
coronary syndrome, 2 groups were identified: 337
patients with MI (both STEMI and NSTEMI), and
a control group of 445 patients with unstable angina.
Fragmented QRS developed in 224 patients with MI
and 17 with unstable angina (51% vs 3.7%; p < 0.001)
and new Q waves developed in 122 (28%) with
STEMI, 76 (23%) with NSTEMI, and 2 (0.4%) with
unstable angina [15]. In the multivariate Cox regres-
sion analysis, presence of fQRS was associated with
a 68% higher risk of all-cause death (HR 1.68; p =
= 0.003) during mean follow-up period of 34 ± 16
months [15]. In a cohort of 85 patients with no pri-
or history of CAD who underwent primary percu-
taneous coronary intervention (PCI) for acute MI,
48 hour post-procedure ECG were analyzed for the
presence of fQRS and predictive value for major ad-
verse cardiac events (MACE) was assessed [16].
However, there was no clear definition of MACE
in this study. During follow-up of 6.6 ± 2.3 years,
there was significantly higher frequency of MACE
among the patients with fQRS as compared to those
who did not have fQRS (29.4% vs 5.9%; p = 0.003).
In the multivariate Cox regression analysis, fQRS
was an independent predictor of MACE (HR 7.16;
95% CI 3.17–20.11; p = 0.006). Q wave and Q wave
Table 1. Studies assessing fragmented QRS (fQRS) as a predictor for myocardial scar.
Study N Patients population Definition of Results
myocardial scar
Das 479 Consecutive patients with A myocardial scar was Sensitivity:
et al. [8] and without prior history defined by a total regional fQRS = 85.6%; Q wave = 36.3%;
of CAD referred for SPECT sum stress score and sum fQRS and/or Q wave = 91.4%
with QRS < 120 ms rest score ≥ 3 and a regional Specificity:
 sum difference score £ 2, fQRS = 89.4%; Q wave = 99.2%;
corresponding to a major fQRS and/or Q wave = 89%
coronary artery region
Das 879 Consecutive patients Myocardial scar defined as Sensitivity for scar
et al. [9] with QRS ≥ 120 ms fixed perfusion (> 2 segments)  fQRS = 86.8%
referred for SPECT or total occlusion or > 70% Specificity = 92.5%;
or cardiac angiography occlusion of major coronary PPV = 92; NPV = 87.5
artery with akinesia or dyskinesia
of respective left ventricular wall
demonstrated by left ventri-
culogram or echocardiography
Wang 460 Consecutive patients Scar was defined as fixed Sensitivity:
et al. [13] with or without CAD and mixed viability defects fQRS = 31.7%; Q wave = 18.3%;
referred for SPECT fQRS and  Q wave = 1.7%
Specificity:
fQRS = 83.6%; Q wave = 98.1%;
fQRS and Q wave = 98.9%
Carey 138 Patients with ischemic Infarct volume was quantified Poor correlation between
et al. [14] cardiomyopathy by insulin-stimulated scar on PET and fQRS
evaluated by PET 18F-2-fluoro-2-deoxyglucose Sylvester QRS
Score better in predicting
infarct volume
CAD — coronary artery disease; SPECT — single photon emission computed tomography; PET — positron emission tomography; PPV — positive
predictive value; NPV — nagative predictive value
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distortion were not significant predictors. This
study demonstrated that presence of fQRS at the
48th hour post-PCI is a strong and significant pre-
dictor of MACE among patients with STEMI [16].
Another approach to evaluate significance and
importance of fQRS in patients with CAD was used
by Toriqoe et al. [17]. The association between the
number of leads with fQRS and the risk of cardiac
death or hospitalization for heart failure was as-
sessed in patients with prior MI. During mean fol-
low-up of 6.4 ± 2.9 years, there were 37 primary
events among 170 patients. In the multivariate Cox
proportional hazard model, only age and a number
of leads with fQRS complex were significant predic-
tors of the cardiac death or heart failure hospitaliza-
tion. It was demonstrated that the presence of ≥ 3 le-
ads with fQRS complex was the most useful predic-
tor of primary event [17]. Table 2 provides data
regarding prognostic significance of fQRS in CAD.
Fragmented QRS complex and ischemic
and non-ischemic cardiomyopathy
The fragmented complex QRS and the risk of
arrhythmic events was evaluated in the cohort of
361 patients with ischemic and non-ischemic cardio-
myopathy who received implantable cardioverter-
-defibrillator (ICD) either for primary or secondary
prevention of sudden cardiac death. Both narrow
and wide complex fQRS was associated with higher
risk of arrhythmic events defined as ICD shock or
anti-tachycardia pacing; however, there was no as-
sociation between fragmentation and mortality [18].
In a cohort of 128 patients with idiopathic dilated
cardiomyopathy with EF equal or less than 40%, Sha
et al. [19], demonstrated that presence of fQRS was
a strong univariate predictor of all-cause mortality
and arrhythmic events (HR 7.90, p = 0.015). How-
ever, since hazard rations from multivariate Cox re-
gression were not reported, it cannot be established
whether fQRS was an independent risk factor for
mortality or arrhythmic events in this study [19].
In the MADIT II (Multicenter Automatic
Defibrillation Implantation Trial) trial, study evalua-
ting the effect of ICD in the patients with severe LV
ischemic dysfunction (LVEF £ 30%), the presence
of fQRS was not associated with increased risk of
sudden or all-cause mortality in this population [20].
However, there was significant increase in the risk
of sudden cardiac death and all-cause death, in
Table 2. Studies evaluating prognostic value of fragmented QRS (fQRS) in coronary artery disease.
Study N Study population Frequency Follow-up time Study end-points
of fQRS
Das 998 Patients with QRS 27.35% 57 ± 23 All-cause mortality:
et al. [10] < 120 ms who were months HR = 1.07; p = 0.62
referred for nuclear Cardiac events:
stress test    HR 1.62; p = 0.0001
Das 879 Patients referred for 47.20% 29 ± 18 All-cause mortality:
et al. [9] nuclear stress test or months HR = 1.41; p = 0.017
 cardiac catheterization Most predictive of mortality
with QRS ≥ 120 ms   in patients with f-LBBB
Das 896 Patients with acute 51% among 34 ± 16 All-cause mortality:
et al. [15] coronary syndrome  patients with months HR = 1.68; p = 0.003
MI, 17% in
control group
Pietrasik 350 Patients with first 53% on 2-month 23 ± 9 fQRS was not associated
et al. [11] Q-wave MI   follow-up ECG months with increased risk of
cardiac event: cardiac death,
 non-fatal MI or unstable angina.
Only in patients who Q wave,
 fQRS resolved was associated
  with increased risk of event:
HR = 2.68; p = 0.04
Ari 85 Patients with no 40% 6.6 ± 2.3 MACE: HR = 7.16;
et al. [16] prior CAD who years p = 0.006
presented with acute
 MI (STEMI vs NSTEMI)
Torigoe 170 Patients with prior MI ≥ 3 leads 6.4 ± 2.9 Cardiac death or
et al. [17] assessed for number w/fQRS 34% years hospitalization for heart
of leads with fQRS failure: HR = 1.33; p = 0.002
HR — hazard ratio; MACE — major adverse cardiac events; MI — myocardial infarction; CAD — coronary artery disease; LBBB — left bundle branch block
119
Grzegorz Pietrasik, Wojciech Zaręba, QRS fragmentation: Diagnostic and prognostic significance
www.cardiologyjournal.org
MADIT II patients with LBBB and inferior wide
QRS complex fragmentation, indicating regional
variability in the risk [21].
Cheema et al. [22] evaluated the association
between fQRS complex and primary end-point of all-
cause mortality and  secondary end-points specific
cause mortality and appropriate ICD shocks in the
cohort of  842 patients with LV dysfunction (LVEF
£ 35%), both ischemic and non-ischemic etiology.
Fragmented QRS was present in 32.5% of patients.
Mean follow-up of the study was 40 ± 17 months for
entire cohort. There was no significant difference in
event-free survival between patients with fQRS and
without fQRS. Fragmented QRS was not associated
with increased risk of all-cause mortality, arrhyth-
mic mortality and non-arrhythmic mortality. There
was no significant association between study end-
point, when the presence of fQRS complex was strat-
ified by ICD status, the etiology of LV dysfunction,
QRS duration or by individual territories. In conclu-
sion, this study demonstrated no associated between
fQRS, and mortality and arrhythmic events; and
fQRS was not proven to be useful factor in risk strat-
ification of patients eligible for ICD therapy [22].
Similar conclusions were drawn from study by For-
leo et al. [23] in which consecutive 394 patients from
a single center in Italy were assessed for presence
or absence of fQRS prior to the implantation of ICD.
The end-point of the study was all-cause death or ap-
propriate ICD therapy defined as appropriate shock
or appropriate anti-tachycardia therapy. During mean
26.3 ± 17.5 months of follow-up, the event-free sur-
vival was similar between patients with and without
fQRS, indicating no significant role of this parameter
in risk stratification for ICD therapy [23]. Table 3
shows key studies assessing QRS fragmentation in
ischemic and non-ischemic cardiomyopathy.
Fragmentation of QRS complex
and dyssynchrony and cardiac
resynchronization therapy
Basaran et al. [24] correlated fQRS complexes
with cardiac dyssynchrony and myocardial fibrosis
in patients with non-ischemic cardiomyopathy and
narrow QRS complex. Cardiac dyssynchrony was
assessed in 25 patients by echocardiography based
time to peak myocardial contraction (TS) and stan-
dard deviation of TS (TS-SD) in all 12 LV segments,
previously described by Yu et al. [25]. Myocardial
fibrosis was assessed in 20 patients, based on late
gadolinium enhancement (LGE) on cardiac magnet-
ic resonance (CMR). Nineteen (76%) patients had
significant dyssychrony. Out of them, 14 (74%) pa-
tients had fQRS complex either in the most delayed
segment or one of the dyssynchronous segment. In
Table 3. Studies evaluating prognostic value of fragmented QRS in ischemic and nonischemic
cardiomyopathy.
Study N Study population Frequency Follow-up Study end-points
of fQRS time
Das 361 Patients with ischemic and 23% 16.6 ± 10.2 Increased risk of arrhythmic events
et al. [18] non-ischemic CM who months defined as appropriate ATP (150–188)
received ICD for either or appropriate shock (> 181):
primary or secondary HR = 7.62; p < 0.001 No effect on
prevention mortality: HR = 1.18; p = 0.74
Brenyo 1188/209 Patients with ischemic CM 27% 19 ± 12 No effect in total population.
et al. [20] with LBBB (EF £ 30%) who received months Increased risk of death only among
Pietrasik ICD for primary prevention patients with LBBB and inferior
et al. [21] fQRS: HR = 2.30; p = 0.001
Cheema 846 Patients with ischemic and 33% 40 ± 17 All-cause mortality: HR = 0.63;
et al. [22] non-ischemic CM (EF £ 35%) months p = 0.43. Arrhythmic mortality:
HR = 0.49; p = 0.38
Forleo 394 Patients with ischemic and 26% 26 ± 18 Death or ICD therapy — no difference
et al. [23] non-ischemic CM (EF £ 35%) months in frequency of end-points in patient
implanted with ICD for primary with and without fQRS
prevention
Rickard 233 Patients with LVEF £ 40% and 4.4 ± 1.9 All-cause mortality — no difference
et al. [26] NYHA class II–VI undergoing years (44% vs 37%, p = 0.31)
implantation of CRT device No difference in response to CRT
(LVEF, LVEDV, LVESV)
HR — hazard ratio; CM — cardiomyopathy; EF — ejection fraction; CRT —  cardiac resynchronization therapy; ICD — implantable cardioverter-defi-
brillator; LBBB — left bundle branch block; LVEF — left ventricular ejection fraction; LVEDV — left ventricular end-diastolic; LVESV — left ventricular
end-systolic volume; ATP — anti-tachycardia pacing
120
Cardiology Journal 2012, Vol. 19, No. 2
www.cardiologyjournal.org
patients evaluated by CMR, 17 (85%) patients had
LGE and out of them, 13 (76%) patients had fQRS
complexes at the concordant segments. This study
suggested close correlation between fibrosis, dys-
synchrony and the presence of fQRS in patients with
narrow QRS and non-ischemic cardiomyopathy.
Effect of fQRS on the efficiency of cardiac re-
synchronization therapy (CRT) was assessed by
Rickard et al. [26] in the cohort of 233 patients with
LVEF £ 40% and NYHA class II–VI undergoing im-
plantation of CRT device. Presence of fQRS was as-
sessed on 12-lead standard ECG prior to the implan-
tation. The end-points of the study were LVEF, LV
end-diastolic and LV end-systolic volumes and all-
cause mortality. During mean follow-up of 4.4 ± 1.9
years, there was no difference in all-cause mortality
between patients with and without fQRS (44% vs
36.8%; p = 0.31). In conclusion, this study showed
no significant association between fQRS and response
to CRT, and no effect of fQRS complex on the all-cause
mortality among the patients on CRT [26].
Brugada syndrome
Morita et al. [27] assessed the presence of fQRS
complex among 115 patients with Brugada syndrome
type I. Thirteen patients had prior ventricular fibril-
lation (VF), 28 had syncope, and 74 were asymptom-
atic. Fragmented QRS was assessed in pre-cordial
leads: V1, V2 and V3. To exclude the patients with
normal RBBB with additional spikes within QRS
complex, abnormal QRS fragmentation was defined
as ≥ 4 spikes in one or ≥ 8 spikes in all of V1, V2 and
V3 leads. Fragmented QRS was present in 43% of
patients, and more frequently in the VF group.
Among the patients from the study who received
ICD, patients with fQRS had frequent recurrence of
syncope due VF during first 4 years of follow-up.
Syncope due to ventricular tachycardia was rare
among the patients without fQRS. This study sug-
gested that multiple spike within QRS complex in-
dicates the presence of an arrhythmogenic substrate
with multiple areas of conduction slowing in a rela-
tive large tissue mass [27].
Arrhythmogenic right
ventricular dysplasia
Peters et al. [28] analyzed ECG of 360 arrhyth-
mogenic right ventricular dysplasia (ARVD) diag-
nosed patients and 52 control patients for the pres-
ence of fQRS in either 1 right precordial lead or in
more than 1 lead including all standard leads. Frag-
mented QRS was found in 306 (85%) ARVD patients
and only in 2 (4%) control subjects. There was no
significant association between presence of fQRS
in any leads and cardiac events; however, presence
of fQRS complex in right precordial leads seemed
to be an important screening tool to evaluate ECG
suspicious for ARVD [28].
Acquired long QT syndrome
Frequency of fQRS was assessed in 70 patients
with acquired severe QT prolongation (QTc ≥ 550 ms).
Thirty-two patients had syncope or torsades de
pointes (TdP) and 38 did not have any event. Fre-
quency of fQRS was significantly higher in a synco-
pe/TdP group then in asymptomatic group (81% vs
21%; p < 0.01). In addition, syncope/TdP group had
longer QT, longer TpTe and higher U wave than as-
ymptomatic group. This study suggested that frag-
mentation of QRS complex might be a predisposing
factor for developing TdP among the patients with
acquired prolongation of QT [29].
Miscellaneous diseases
There has been an interest in fQRS as a screen-
ing tool in a systemic disease with cardiac involve-
ment. Kadi et al. [30] assessed the frequency of
fQRS complexes in patients with rheumatoid arthri-
tis (RA) and in control group of patients with fibro-
myalgia rheumatica. Patients with BBB and cardio-
vascular disease were excluded. Fragmented QRS
were more often found among the patients with RA
than a control group (37.5% vs 5.7%; p = 0.001).
Duration of a disease was significantly associated
with a presence of fQRS [30].
In a cohort of 112 patients with biopsy-proven
sarcoidosis, baseline ECG were evaluated for pres-
ence of fQRS [31]. Fifty two patients were diag-
nosed with cardiac sarcoidosis and 60 did not have
cardiac involvement. Among individuals with car-
diac involvement, fQRS was more prevalent than
those without cardiac involvement (75% vs 33.9%;
p < 0.01). Similarly BBB were more common in
patients with cardiac involvement. Study conclud-
ed that the presence of fQRS or BBB in patients
with sarcoidosis should raise suspicion for cardiac
involvement and prompt further evaluation [31].
Summary
Presence of fragmented QRS represents dis-
tortion of signal conduction and depolarization pro-
cess within ventricles which is related to myocar-
dial scar/myocardial ischemia or myocardial fibro-
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sis. The meaning/predictive value of this ECG
marker seems to be different in different popula-
tions. Still there is dispute if it can predict the pres-
ence of myocardial scarring in patients with CAD.
Two major studies demonstrated different degree
of sensitivity of fragmented QRS [8, 13]. In patients
with stable CAD and patients with acute MI, QRS
fragmentation seems to be good predictor of cardi-
ac events, however, does not affect mortality [10].
In patients with non-ischemic cardiomyopathy, frag-
mentation of narrow QRS complex seems to corre-
late with degree of fibrosis and dyssynchrony and
importantly may influence the response for CRT
[24]. However, based on clinical studies with larg-
er number of patients with current indications for
cardiac resynchronization, fragmentation is not ef-
fecting the therapy response [26]. In patients with
LV dysfunction, there is no clear evidence that pres-
ence of fragmented QRS could predict arrhythmic
events [20–23].
Major factor limiting utility of fragmentation is
a subjective assessment of significant fQRS. Since
fQRS represents alternation and inhomogeneity in
ventricular activation, which based on studies quoted
in this review, may have significant clinical diagnos-
tic and prognostic value in different cardiovascular
diseases, there is a need for more objective evalu-
ation of depolarization alternation process. One of
the future directions of more objective analysis of
depolarization process is an analysis of high fre-
quency QRS components. HyperQ is a novel tech-
nology allowing measurement of QRS signal ampli-
tude and morphology and seemed to be more sen-
sitive than ST-T changes during exercise stress
testing for detecting ischemia [32].
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